- Global Pharma News & Resources

Biopharmaceutical Applications are Key to Developments in Plasmapheresis Industry

Plasmapheresis is a process which filters blood and gets rid of potentially harmful antibodies from the fluid. Similar to the procedure of dialysis, the process of plasmapheresis is primarily utilized to target antibodies, only from the plasma in the blood.

The recent increase in incidences of autoimmune diseases, has resulted in a substantial increase in the demand for plasmapheresis procedures around the world. The rising demand for extracorporeal therapies is expected to support the growth of the global market for autoimmune diseases.

The increased incidences of ailments such as lupus, type 1 diabetes, temporal arthritis, celiac disease, and rheumatoid arthritis are playing major roles in the rising demand for plasmapheresis procedures. The demand is also set to be supported by the range of treatments for sickle cell disease and neurotherapy.

Request Sample Report-

The global plasmapheresis market is expected to grow at a healthy CAGR of ~ 7.2 per cent through the end of the forecast period in 2026. This growth will account for a value of USD 1500 million in this period.

Autoimmune Diseases to Create Demand

Around the globe, the increased proliferation of autoimmune disease is expected to aid demand for plasmapheresis and other extracorporeal therapies. Conditions such as lupus can adversely affect vital organs such as the heart, lungs, kidneys, and skin among others.

The adoption of plasmapheresis is rising to aid in the circulation of immune complexes in the blood of patients, and also gets rid of putative pathogenic autoantibodies. Such processes are rapidly gaining traction, as manufacturers of plasmapheresis devices integrate novel technologies and features in their offerings like apheresis machines, for superior performance of instruments around the world. With such changes in the industry, the global plasmapheresis market is expected to witness substantial growth in the years ahead.

Read Report Overview-

Biopharmaceutical Research to Become Major Influence

The rising demand for plasmapheresis procedures has resulted in substantial demand for a variety of instruments in a global market. The plasmapheresis instruments segment is anticipated to gain greater growth. In addition disposable products are also expected to display a strong CAGR during this period.

Further plasma collection processes is expected to gain substantially in terms of revenue, while the CAGR for centrifugal applications is expected to witness a higher rate throughout the forecast period. Major portion of the revenue is projected to come from biopharmaceutical entities, while others will display robust CAGR as well.

The high demand for donation for plasma is a key factor behind the rise of plasmapheresis. Plasma is needed for treatments of heart disease, anemia, childbirth, stomach ailments, burns, blood loss, and cancer among others. In addition, the high use of fractionation is also key to investments in research and development for medications by a range of biopharmaceutical entities.

The higher demand for biopharmaceutical medicines for cancer, diabetes, arthritis, and tumors will also aid in the growth of plasmapheresis. Consequently, the higher production of biopharma and blood products are expected to continue to positively impact growth of the plasmapheresis market for the years to come.

Request Research Methodology-

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us


11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States



Editor Details

Last Updated: 13-Jan-2020